Antioxidant status of hypercholesterolemic patients treated with LDL apheresis

被引:8
|
作者
Lepage, S
BonnefontRousselot, D
Bruckert, E
Bourely, B
Jaudon, MC
Delattre, J
Assogba, U
机构
[1] HOP LA PITIE SALPETRIERE, SERV ENDOCRINOL & METAB, F-75651 PARIS 13, FRANCE
[2] HOP LA PITIE SALPETRIERE, CTR HEMOBIOL TRANSFUS, F-75651 PARIS 13, FRANCE
关键词
antioxidants; vitamins; trace elements; hypercholesterolemia; LDL apheresis;
D O I
10.1007/BF00050998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidation of low density lipoprotein is involved in the pathogenesis of atherosclerosis. Epidemiological studies suggest a negative correlation between the occurrence of cardiovascular diseases and blood concentrations of lipophilic antioxidants such as vitamins A and E and beta-carotene. Trace elements, such as selenium, zinc, and copper, are involved in the activity of the antioxidant enzymes glutathione peroxidase and superoxide dismutase. The aim of this study was to determine the antioxidant and trace element status of patients with severe hypercholesterolemia who had been treated with dextran-sulphate low-density lipoprotein apheresis in comparison with two control populations, normocholesterolemic subjects and untreated hypercholesterolemic patients. Our results showed that, patients treated with LDL apheresis, compared with normocholesteromic subjects, were not deficient in vitamin E, beta-carotene, and copper, but had low plasma levels of selenium, zinc, and vitamin A. The low selenium and vitamin A levels were due to the LDL-apheresis treatment, and the hypercholesterolemia might have provoked the low plasma levels of zinc. This study pointed out the potential benefits of supplemental selenium, zinc, and vitamin A in patients being treated with LDL apheresis.
引用
收藏
页码:567 / 571
页数:5
相关论文
共 50 条
  • [1] SELENIUM DEFICIENCY IN HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH LDL APHERESIS
    JAUDON, MC
    ASSOGBA, U
    BOURELY, B
    DAIROU, F
    BRUCKERT, E
    DELATTRE, J
    [J]. LANCET, 1994, 343 (8906): : 1160 - 1160
  • [2] Increased resistance of LDL subfractions to oxidation in severe hypercholesterolemic patients treated with LDL-apheresis
    Lepage, S
    Nigon, F
    BonnefontRousselot, D
    Bruckert, E
    Assogba, U
    Delattre, J
    Chapman, J
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 215 - 215
  • [3] PREFERENTIAL DEPLETION OF SELENOPROTEIN-P IN HYPERCHOLESTEROLEMIC PATIENTS TREATED BY LDL-APHERESIS
    PERSSONMOSCHOS, M
    BONNEFONTROUSSELOT, D
    ASSOGBA, U
    BRUCKERT, E
    JAUDON, MC
    DELATTRE, J
    AKESSON, B
    [J]. CLINICA CHIMICA ACTA, 1995, 240 (02) : 209 - 212
  • [4] Effect of lipoprotein apheresis on oxidative stress and antioxidant status in familial hypercholesterolemic patients
    Kurtoglu, E
    Ugur, A
    Gonen, MS
    Kisakol, G
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2003, 26 (11): : 1039 - 1043
  • [5] Effect of lipoprotein apheresis on oxidative stress and antioxidant status in familial hypercholesterolemic patients
    [J]. Kurtoglu, E. (erdalkurtoglu@yahoo.com), 1600, Wichtig Editore s.r.l. (26):
  • [6] Pregnancy of homozygous familial hypercholesterolemic patients with coronary artery disease treated with LDL-apheresis
    Nagumo, A.
    Makino, H.
    Miyamoto, Y.
    Yoshimasa, Y.
    Ikeda, T.
    Chiba, Y.
    Yokoyama, S.
    Tsushima, M.
    Yamamoto, A.
    Harada-Shiba, M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 564 - 564
  • [7] LIPOPROTEIN PARTICLES IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH PORTACAVAL-SHUNT AND LDL APHERESIS
    GAIRIN, D
    MONARD, F
    CACHERA, C
    BARD, JM
    AMOUYEL, P
    DURIEZ, P
    TACQUET, A
    FRUCHART, JC
    [J]. CLINICA CHIMICA ACTA, 1990, 193 (03) : 165 - 179
  • [8] LDL apheresis improves deranged cardiovagal modulation in hypercholesterolemic patients
    Reimann, Manja
    Julius, Ulrich
    Haink, Kristin
    Lippold, Birgit
    Tselmin, Sergey
    Bornstein, Stefan R.
    Reichmann, Heinz
    Ruediger, Heinz
    Ziemssen, Tjalf
    [J]. ATHEROSCLEROSIS, 2010, 213 (01) : 212 - 217
  • [9] Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins
    Geiss, HC
    Otto, C
    Hund-Wissner, E
    Parhofer, KG
    [J]. ATHEROSCLEROSIS, 2005, 180 (01) : 107 - 112
  • [10] LDL-apheresis removes serum amyloid P and A in hypercholesterolemic patients
    Palumbo, B
    Cardinali, L
    Sinzinger, H
    [J]. THROMBOSIS RESEARCH, 2000, 97 (06) : 491 - 494